Physician profile
Roberta E Reilly
NPI 1447251434
$2,328.42
in general payments reported to CMS, 2019-2025
23 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $118 · 2021: $347 · 2022: $430 · 2023: $446 · 2024: $344 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.05 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $458.80 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $214.84 | 2019-2024 | |
| Coopersurgical, INC. | $206.04 | 2021-2024 | Paragard T 380a, Paragard T 380a, Summit Doppler |
| Astellas Pharma US INC | $169.25 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $160.72 | 2023 | |
| Axonics, INC. | $141.23 | 2022 | |
| Inspire Medical Systems, INC. | $140.68 | 2024 | Inspire |
| Therapeuticsmd, INC. | $110.58 | 2019-2022 | |
| Pfizer INC. | $91.40 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $87.88 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $81.64 | 2019-2023 | Omni Hysteroscope, Myosure Tissue Removal Device |
| Exact Sciences Corporation | $75.02 | 2024 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $71.79 | 2019-2020 | |
| Duchesnay USA Incorporated | $68.99 | 2019 | |
| Millicent US INC | $46.90 | 2019-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $44.51 | 2022 | |
| Amag Pharmaceuticals, INC. | $39.20 | 2019 | |
| Aspira Women'S Health INC | $34.68 | 2019 | |
| Mallinckrodt Enterprises LLC | $24.00 | 2019 | |
| Myovant Sciences INC. | $19.64 | 2022 | |
| Agile Therapeutics, INC. | $14.93 | 2021 | |
| Lupin INC. | $14.54 | 2019 | |
| Merck Sharp & Dohme LLC | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberta Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.